A consortium led by the CAS Institute of Microbiology in Beijing has identified a new factor (MfpB = Mycobacterium fluoroquinolone resistance protein B) which confers resistance towards fluoroquinolones, the preferred tuberculosis drug. The protein is a GTPase.
Jun TAO et al., Nucleic Acid Research, doi: 10/1093/nar/gks1351